STAT+: Gilead gets a boost from California court in a case over slow-walking an HIV drug
STAT
MAY 2, 2024
Back in 2004, Gilead explained its decision by maintaining the medicines were not sufficiently different, but internal documents produced in court suggested the company made this move in order to maximize profits.
Let's personalize your content